Abstract:Our understanding of infection biology is based on experiments in which pathogen or host proteins are perturbed by small compound inhibitors, mutation, or depletion. This approach has been remarkably successful, as, for example, demonstrated by the independent identification of the endosomal membrane protein Niemann-Pick C1 as an essential factor for Ebola virus infection in both small compound and insertional mutagenesis screens (Côté, Nature 477:344-348, 2011; Carette et al., Nature 477:340-343, 2011). However, many aspects of host-pathogen interactions are poorly understood because we cannot target all of the involved molecules with small molecules, or because we cannot deplete essential proteins. Single domain antibody fragments expressed in the cytosol or other organelles constitute a versatile alternative to perturb the function of any given protein by masking protein-protein interaction interfaces, by stabilizing distinct conformations, or by directly interfering with enzymatic activities. The variable domains of heavy chain-only antibodies (VHHs) from camelid species can be cloned from blood samples of animals immunized with the desired target molecules. We can thus exploit the ability of the camelid immune system to generate affinity-matured single domain antibody fragments to obtain highly specific tools. Interesting VHH candidates are typically identified based on their affinity toward immobilized antigens using techniques such as phage display.The phenotypical screening approach described here allows the direct identification of VHHs that prevent infection of cells with influenza A virus (IAV) or other pathogens. The VHH repertoire is cloned into a lentiviral vector, which is used to generate pseudo-typed lentivirus particles. Target cells are transduced with the lentivirus, so that every cell inducibly expresses a different VHH. This cell collection is then challenged with a lethal dose of virus. Only the cells which express a VHH that prevents infection by targeting virus proteins or host cell components essential for infection will survive. We can thus identify critical target molecules including vulnerable epitopes and conformations, render target molecules accessible to informative perturbation studies, and stabilize intermediates of virus entry for detailed analysis.

Selecting Agonists from Single Cells Infected with Combinatorial Antibody Libraries.

Selection of Antibodies That Regulate Phenotype from Intracellular Combinatorial Antibody Libraries

Antibodies from Combinatorial Libraries Use Functional Receptor Pleiotropism to Regulate Cell Fates

Selection of multiple agonist antibodies from intracellular combinatorial libraries reveals that cellular receptors are functionally pleiotropic.

Use of Baculovirus MHC/peptide Display Libraries to Characterize T‐cell Receptor Ligands

Autocrine Signaling Based Selection of Combinatorial Antibodies That Transdifferentiate Human Stem Cells.

A Proximity Based General Method for Identification of Ligand and Receptor Interactions in Living Cells.

A novel lentiviral scFv display library for rapid optimization and selection of high affinity antibodies.

Combinatorial Libraries Against Libraries For Selecting Neoepitope Activation-Specific Antibodies

Converting Stem Cells to Dendritic Cells by Agonist Antibodies from Unbiased Morphogenic Selections

Agonist Discovery for Membrane Proteins on Live Cells by Using DNA-encoded Libraries

A rapid novel strategy for screening of antibody phage libraries for production, purification, and functional characterization of amber stop codons containing single‐chain antibody fragments

A co-expression system based on phage and phagemid to select cognate antibody-antigen pairs in vivo

Prevention of Cell Death by Antibodies Selected from Intracellular Combinatorial Libraries.

Direct Antibody Isolation on Cells Using Affinity-Tag-Guided Proximity Selection

Function-based High-Throughput Screening for Antibody Antagonists and Agonists Against G Protein-Coupled Receptors

Generation and Next-Generation Sequencing-Based Characterization of a Large Human Combinatorial Antibody Library

A platform for the early selection of non-competitive antibody-fragments from yeast surface display libraries

Phenotypic Lentivirus Screens to Identify Antiviral Single Domain Antibodies

Identification of target and function specific antibodies for effective drug delivery.

Two-dimensional High-Throughput On-Cell Screening of Immunoglobulins Against Broad Antigen Repertoires